ArticlePDF Available

Composition of Breast Fluid of a Man with Galactorrhea and Hyperprolactinaemia*

Authors:

Abstract

It has been previously reported that men with and without known disease can produce milk, but no studies to date have demonstrated that their secretion contains milk constituents produced specifically by the breast. The present study shows the presence of lactose, alpha-lactalbumin, and lactoferrin in the breast secretion of a 27-yr-old male who had galactorrhea associated with hyperprolactinaemia. The concentrations of lactose, proteins, and electrolytes in the breast secretion of this man are within the range of colostrum and milk obtained from normal lactating women.
0021-972X/81/5203-0581$02.00/0
Journal of Clinical Endocrinology and Metabolism
Copyright©
1981
by The Endocrine Society
Vol.
52,
No.
3
Printed in U.S.A.
Composition of Breast Fluid of a Man with Galactorrhea
and Hyperprolactinaemia*
J. K. KULSKI, P. E. HARTMANN,
AND
D. H. GUTTERIDGE
Department of Biochemistry, University of Western Australia, and the Endocrinology Unit, Sir Charles
Gairdner Hospital, Nedlands,
6009,
Western Australia
ABSTRACT. It has been previously reported that men with
and without known disease can produce milk, but no studies to
date have demonstrated that their secretion contains milk con-
stituents produced specifically by the breast. The present study
shows the presence of lactose, a-lactalbumin, and lactoferrin in
the breast secretion of a 27-yr-old male who had galactorrhea
associated with hyperprolactinaemia. The concentrations of
lac-
tose,
proteins, and electrolytes in the breast secretion of this
man are within the range of colostrum and milk obtained from
normal lactating women. (J Clin Endocrinol Metab 52: 581,
1981)
M
OST studies on human milk composition have
been limited to the period of the initiation and
maintenance of normal lactation which is appropriate to
the needs of the newborn
(1,
2). However, lactation may
also occur at a time which is inappropriate to the physi-
ological status of either men or women, with or without
known endocrinopathies (3-6). In most reported cases,
the diagnosis of inappropriate lactation (galactorrhea)
has been based on the expression of breast fluid without
an analysis of its composition (3-6). In one study, the
breast secretion of a young man with hypogonadism and
galactorrhea was analyzed for the presence of triglycer-
ides,
cholesterol, and nitrogen, the levels reportedly were
in keeping with human female milk (7). However, no
study has yet demonstrated the presence of specific milk
constituents, such as lactose, a-lactalbumin, or casein, in
the breast secretion of men with clinical galactorrhea.
Therefore, the present study was undertaken to deter-
mine 1) whether the breast secretion of a man who had
galactorrhea associated with elevated levels of serum
PRL contained specific or nonspecific milk constituents
and 2) how the concentration of these constituents com-
pared to the levels in colostrum and milk of normal
lactating women.
Received August
11,
1980.
Address all correspondence and requests for reprints to: Dr. J. K.
Kulski, Department of Biomedical and Environmental Health Sciences,
School of Public Health, University of California, Berkeley, California
94720.
* This work was supported by a grant from the National Health and
Medical Research Council of Australia.
Subjects and Methods
A 27-yr-old man with galactorrhea and decreased potency
was studied. X-Rays and tomographs demonstrated an enlarged
pituitary fossa, and the concentrations of PRL, FSH, and LH
in his serum were 183 jug/liter (normal, <5 jUg/liter), 3 U/liter
(normal, 3-19 U/liter) and 8 U/liter (normal, 3-22 U/liter),
respectively. Samples of his breast secretion (0.2-1.0 ml) were
expressed manually directly into sterile polypropylene vials
once a month during a 3-month period of study.
Samples of breast secretion also were collected from 52
normal women. Colostrum was collected during the last trimes-
ter of pregnancy and day 1 post partum, and mature milk was
collected between 1-12 months post partum.
The breast fluids of the women and the man were analyzed
for the presence of lactose, total protein, a-lactalbumin, lacto-
ferrin, albumin, immunoglobulin A, Na, K, and Cl using assay
methods previously described (8).
Results and Discussion
The concentrations of lactose, proteins, and electro-
lytes in the colostrum and milk of normal lactating
women and in the breast secretion of a man with galac-
torrhea are shown in Table 1. The results show that the
male breast can synthesize and secrete specific milk
constituents, such as lactose and a-lactalbumin, at ap-
proximately the levels found in the colostrum and milk
of normal lactating women. In addition, the nonspecific
milk proteins (lactoferrin, immunoglobulin A, and albu-
min) and electrolytes in the breast secretion of the man
were at concentrations similar to those found in the
colostrum and milk of normal lactating women. In this
581
Downloaded from https://academic.oup.com/jcem/article-abstract/52/3/581/2677795
by UNIV OF WESTERN AUSTRALIA user
on 13 February 2018
582COMMENTS
JCE & M 1981
Vol 52 No 3
TABLE
1. Comparison between concentrations of milk constituents in
the breast secretion of a male with galactorrhea and the breast secretion
of women
Milk constitu-
ent
Lactose (g/100
ml)
Protein (g/100
ml)
a-Lactalbumin
(g/liter)
Lactoferrin (g/li-
ter)
Albumin (g/liter)
Immunoglobulin
A (g/liter)
Na (mM)
K (mM)
Cl (mM)
Male galactorrhea
Sam-
ple 1
4.1
6.23
4.31
18.0
3.0
9.2
39.0
15.0
37.0
Sam-
ple 2
4.6
5.37
4.21
13.0
4.5
9.9
36.3
16.0
35.0
Sam-
ple 3
6.3
1.65
2.92
5.1
1.5
2.0
14.0
21.0
17.0
Breast secretion from
women"
Colostrum
2.34 ± 0.65
6.83 ± 3.2
3.41 ± 0.89
22.8 ± 12.0
3.4 ± 1.7
9.74 ± 6.4
61.9 ± 16.0
14.5 ± 5.1
56.3 ± 62.0
Milk
6.6 ± 0.62
1.4 ± 0.9
1.8 ± 0.42
1.2 ± 0.46
0.4 ± 0.08
0.95 ± 0.2
8.3 ± 6.4
13.4 ± 20.3
11.8 ± 3.8
Colostrum was collected during late pregnancy and 1 day post
partum, and the milk was colllected during established lactation be-
tween 1-12 months post partum.
" Mean ±
SD.
man, the synthesis and secretion of milk was related to
pituitary dysfunction and high levels of serum PRL, a
hormone known to play an important role in the initia-
tion and maintenance of lactation in humans (9) and
other species (10).
Only one previous report has stressed the importance
of defining abnormal breast fluid as milk on the basis of
its content of a specific milk constituent (6). Lactose, a-
lactalbumin (which functions as one component in lac-
tose synthase for the production of lactose), and casein
are the only milk constituents known to be synthesized
specifically by the mammary gland (11,12). The analysis
of inappropriate breast discharges for these constituents
offers a more specific demonstration that the fluid se-
creted is milk. In this connection, further studies of the
composition of normal and inappropriate breast secre-
tions may help to provide a better understanding of the
factors controlling the complex process of lactation, par-
ticularly if such studies are related to the hormone levels
in the blood and mammary secretion (13-15) as well as
to diagnosed endocrine disorders.
References
1.
Macy IG, Kelly HJ, Sloan RE 1953 The Composition of Milks.
Publication no. 254, National Academy of Science-National Re-
search Council, Washington DC, p 25
2.
Peaker M 1976 Lactation, some cardiovascular and metabolic con-
sequences,
and the mechanisms of lactose and ion secretion into
milk. In: Wolstenholme G (ed) Breast Feeding and the Mother,
CIBA Foundation Symposium
45.
Excerpta Medica, London p 87
3.
Vorherr H 1974 The Breast: Morphology, Physiology and Lacta-
tion. Academic Press, New York
4.
Tyson JE, Zacur HA 1975 Diagnosis and treatment of abnormal
lactation. Clin Obstet Gynecol 18:65
5.
Kleinberg DL, Noel GL, Frantz AG 1977 Galactorrhea: a study of
235 cases, including 48 with pituitary tumor. N Engl J Med 296:689
6. Hagler L, Coppes RI, Block MB, Hofeldt FD, Herman RH 1975
Clinical implications of lactose—positive breast secretions in non-
puerperal females. Obstet Gynecol 46:302
7.
Volpe R, Killinger D, Bird C, Clark AF, Friesen H 1972 Idiopathic
galactorrhea and mild hypogonadism in a young adult male. J Clin
Endocrinol Metab 35:684
8. Hartmann PE, Kulski JK 1978 Changes in the composition of the
mammary secretion of women after abrupt termination of breast
feeding. J Physiol (Lond) 275:1
9. Kulski JK, Hartmann PE, Martin J, Smith M 1978 Effects of
bromocriptine mesylate on the composition of the mammary secre-
tion in non-breast feeding women. Obstet Gynecol 52:38
10.
Schams D 1976 Hormonal control of lactation. In: Wolstenholme G
(ed) Breast Feeding and the Mother, CIBA Foundation Symposium
45.
Excerpta Medica, London p 27
11.
Brew K, Hill RL 1975 Lactose biosynthesis. Rev Physiol Biochem
Pharmacol 72:105
12.
Bezkorovainy A 1977 Human milk and colostrum proteins. A re-
view. J Dairy Sci 60:1023
13.
Kulski JK, Smith M, Hartmann PE 1977 Perinatal concentrations
of progesterone, lactose and a-lactalbumin in the mammary secre-
tion of women. J Endocrinol 74:509
14.
Wynder EL, Hill P 1977 Prolactin, oestrogen and lipids in breast
fluid. Lancet 2:280
15.
Healy DL, Rattigan S, Hartmann PE, Herington AC, Burger HG
1980
Prolactin in human
milk:
correlation with lactose, total protein
and a-lactalbumin levels. Am J Physiol 238:E83
Downloaded from https://academic.oup.com/jcem/article-abstract/52/3/581/2677795
by UNIV OF WESTERN AUSTRALIA user
on 13 February 2018
... When we refer to relevant publications about the biochemical nature of galactorrhea we encounter few studies. [26][27][28][29] A former research revealed that "the chemical analysis of secretions from galactorrhea and of normal human breast milk are not identical. Three constituents, i.e. lactose, total lipids and total proteins were found present in significantly lower concentrations in secretions from patients with galactorrhea than in normal breast milk. ...
... Three constituents, i.e. lactose, total lipids and total proteins were found present in significantly lower concentrations in secretions from patients with galactorrhea than in normal breast milk. 26 27 Lactoferrin has antimicrobial activity (bacteriocide, fungicide, antiparasitic, antiviral), anti-cancer, and anti-allergic functions and ...
Article
Full-text available
Numerous medical prescriptions are given in the 14 th and 15 th century medical manuscripts of the Ottoman period. However, only a small number of pharmaceutical preparations contain non-lactational milk production medically named galactorrhea. In this study, prescriptions which contain non-lactational milk are compiled from Turkish medical manuscripts of the 14 th and 15 th centuries. The non-lactational milk discharge is used as an ingredient or a medium or a coating in a medical composition, as well as a separate medical substance for the treatment of inflammation and suppuration. For example, in the 15th century, İbn-i Şerif recommended non-lactational milk in the treatment of lung diseases with cough, sputum and fever.The use of non-lactational milk as a drug for conjunctivitis, lung infection, ear infection, etc. have been discussed with examples in the early period of Ottoman medicine.
Article
Galactorrhoea is the secretion of milk from the breast in non-physiological circumstances. It is rare in males of any age. We report the case of an adult male who presented with enlarged breasts and tenderness of the left breast, with milky discharge. Bilateral subcutaneous mastectomies were performed.
Article
PIP Galactorrhea refers to the secretion of a milky fluid from the breast, occurring either spontaneously or with manual expression, in the absence of pregnancy or the postpartum state. The development of a sensitive and specific radioimmunoassay for human prolactin during the last decade along with improved neuroradiologic techniques have greatly expanded understanding of nonpuerperal lactation. Discussion reviews the pevalence of galactorrhea, the etiology of hyperprolactinemia and/or galactorrhea, pituitary tumor, parapituitary lesions, oral contraceptive (OC) associated galactorrhea, drug induced galactorrhea, hypothyroidism, neurogenic stimulation, idiopathic galactorrhea, clinical features of galactorrhea, laboratory evaluation, neuroradiologic evaluation, hypocycloidal tomography, carotid angiography, pneumoencelphalography (PEG), computerized tomography (CT), management, and therapy. The prevalence of galactorrhea in women is reported to range from 0.1-32%. Much of this variability can be attributed to differences in examination techniques, the investigator's definition of galactorrhea, and the patient population studied. Nonpuerperal hyperprolactinemia is an important cause of galactorrhea and is found in 49-77% of cases, but hyperprolactinemia does not appear to be the sole prerequisite for galactorrhea since only 15-68% of patients with excessive prolactin secretion develop galactorrhea. Pituitary tumors are the most important diagnostic consideration have been reported in approximately 20% of cases of galactorrhea and 34% of cases of amenorrhea galactorrhea. Parapituitary lesions, an infrequent but important cause of hyperprolactinema and galactorrhea, can result in excessive prolactin secretion by interfering with either the production or delivery of prolactin inhibitory factor to the lactotrope cells of the anterior pituitary gland. OC associated galactorrhea is a frequent diagnosis in patients with nonpuerperal lactation and has been implicated in 10-14% of cases. OC discontinuation can also produce galactorrhea. Pharmacologic agents are a common cause of hyperprolactinemia and/or galactorrhea. A variety of forms of neurogenic stimulation have been linked to hyperprolactinemia and/or galactorrhea. Idiopathic galactorrhea is a diagnosis of exclusion and is applicable to 40-50% of patients with nonpuerperal lactation. In patients with galactorrhea, the presence of the abnormal, milky breast secretion may be the sole symptom or it may be associated with other pertinent clinical findings. All patients with galactorrhea should have measurements of thyroid stimulating hormone and serum prolactin performed. The optimal management of patients with prolactinomas is somewhat controversial. Surgical resection remains the most definitive form of therapy with the transsphenoidal approach most frequently used. Recent invesitgations show promise for bromocriptine as an alternative therapeutic modality.
Article
Breast volume and morphology of eight subjects were measured before conception and at intervals throughout pregnancy until 1 month of lactation. Breast volume before conception ranged from 293 to 964 ml. At the end of pregnancy the volume of breast tissue had increased by 145+/-19 ml (mean+/-S.E.M., n = 13 breasts, range 12-227 ml) with a further increase to 211+/-16 ml (n = 12 breasts, range 129-320 ml) by 1 month of lactation. Urinary excretion of lactose increased at 22 weeks of pregnancy, signalling the capacity of the breast to synthesize lactose at this time. During pregnancy, both the change in breast volume and the change in cross-sectional area of the areola were related to the concentration of human placental lactogen in the plasma. The growth of the nipple and the rate of excretion of lactose were related to the concentration of prolactin in the plasma. During the first 3 days after birth, the rate of excretion of lactose was related to the rate of excretion of progesterone. There was no relationship between the growth of the breast during pregnancy and the amount of milk produced at 1 month of lactation.
Article
Full-text available
Excerpt Departments of Biochemistry and *Obstetrics and Gynaecology, University of Western Australia, Nedlands, Australia (Received 25 April 1977) The hormonal signal for lactogenesis in a number of different species is considered to be a precipitous fall in the concentration of progesterone in the blood during late pregnancy (see Hartmann, Trevethan & Shelton, 1973). In women, the major fall in the level of blood progesterone just after delivery (Yannone, McCurdy & Goldfien, 1968) precedes lactogenesis by 2-3 days (Reynolds, 1972). However, the effects of this fall may be modified to some extent by progesterone, which accumulates in the milk (Heap, Gwyn, Laing & Walters, 1973). Progesterone could be the 'lipid-soluble substance' in the mammary secretion which Linzell & Peaker (1974) suggested might control the final stage of lactogenesis. The purpose of the present investigation was to compare changes in the concentrations of progesterone, lactose and α-lactalbumin in the mammary secretion of women
Article
Full-text available
A double-blind trial was performed on 26 women, who had elected not to breast-feed their infants, to determine the effect of bromocriptine mesylate (2.5 mg twice daily for 14 days postpartum) on the composition of the mammary secretion during lactogenesis. Mammary secretion (less than 5.0 ml) was collected from each breast of each woman at daily intervals during the 14-day treatment period and the progressive changes in the concentration of the milk constituents, lactose, alpha-lactalbumin, serum albumin, total protein, lactoferin, IgA, IgG, sodium and potassium were determined. The degree of milk leakage and breast engorgement were also assessed. Both the subjective assessments and the changes in the concentration of the milk constituents demonstrated that lactogenesis occurred between about Day 2 and Day 5 postpartum in the placebo group (in the absence of the suckling stimulus) but was suppressed in the bromocriptine-treated group.
Article
Full-text available
1. The composition of mammary secretion has been followed in seven women before and after abrupt termination of breast feeding. The period of full lactation was 39 days for 1 woman and a mean of 332 days (range 251--443 days) for the six others. Small samples of mammary secretion (0.5--5.00 ml.) were collected by manual expression from three women at monthly intervals throughout 12 months of lactation and from seven women at frequent intervals for 42 days of involution. 2. During full lactation (12 months, three women) the mean values (+/- S.E. of mean) for lactose, total protein, alpha-lactalbumin, Na, K and Cl were 7.03 +/- 0.13 g/100 ml., 1.68 +/- 0.08 g/100 ml., 163 +/- 6.39 mg/100 ml., 8.5 +/- 0.90 mM, 13.4 +/- 0.34 mM and 11.93 +/- 0.53 mM, respectively. 3. After termination of breast feeding, the concentrations of lactose and K decreased while Na, Cl, fat and total protein increased progressively over 42 days. The increase in the protein content was contributed to by increases in the concentration of lactoferrin, IgA, IgG, IgM, albumin, alpha-lactalbumin and casein. There was no significant difference in the concentration of the milk constituents between the right and left breast throughout full lactation and after its termination. 4. These observations indicated that the secretory capability of the mammary gland of women changed dramatically after complete cessation of breast feeding but that the involuting gland remained partially functional for a long period.
Article
Human milk contains a number of factors that are protein in nature, which apparently enhance the resistance of the breast-fed infant against disease. Among such factors are lactoferrin, immunoglobulin A, the Lactobacillus bifidus growth-promoting glycoproteins, and lysozyme. Lactoferrin is believed to exert its bacteriostatic action mainly in concert with specific antibacterial immunoglobulins. The immunoglobulins may, in turn, act in concert with the large numbers of white blood cells in human milk and colostrum. α-Lactalbumin, a major component of human milk, is important both from a nutritional point of view, and as a component of the enzyme system biosynthesizing lactose. It is structurally homologous to lysozyme of both human milk and hen's egg white. The most abundant component of the casein fraction of human milk is β-casein, which exists in the form of genetically-determined polymorphs. The polymorphs apparently differ in their phosphate content only. The amino acid sequence of the N-terminal region of human milk β-casein bears a strong structural homology to that of bovine milk β-casein. Human α-casein is also in the form of genetically-determined polymorphs; however, it has not been purified and characterized. Human κ-casein is a glycoprotein which releases a glycomacropeptide when acted upon by rennin. Though it has not been characterized to any great extent, there is evidence that there may be several forms of κ-casein in human milk. Also the nature of the glycomacropeptide varies depending on whether purified κ-casein or whole casein fractions are subjected to the action of rennin. The amino acid sequence of a glycomacropeptide produced from κ-casein-enriched fraction of human milk casein was structurally homologous to the glycomacropeptides from other species.
Article
Concentrations of prolactin, oestrogens, and lipids were measured in the plasma and breast-duct fluid of 8 non-lactating premenopausal women without a known history of breast disease. Concentrations of prolactin, oestrogen, and triglycerides were significantly higher in ductal fluid than in plasma, but there was little difference with cholesterol concentration. The high concentrations of prolactin and oestrogen found in the ductal fluid of Western women may be relevant to development of breast cancer.
Article
Lactation causes increases in mammary blood flow, gastrointestinal blood flow and cardiac output in the rat, and the suckling-induced release of lactogenic anterior pituitary hormones probably causes these changes, directly or indirectly. Metabolic requirements of lactation in women are similar to those in other animals not artificially selected for a high milk yield but the physiological control of the relationship between milk secretion and nutrient availability is not well understood. The unusual composition of the aqueous phase of human milk (rich in lactose but poor in sodium and potassium ions) can be explained by the same basic mechanisms for secretion of lactose and ions as operate in other animals but with quantitative differences.
Article
Article
Lactation is usually differentiated into three stages - mammary growth, initiation of milk secretion and maintenance of established milk secretion. Each stage is regulated by a complex of metabolic and reproductive hormones: prolactin, growth hormone, corticoids, thyroxin, insulin and, especially for mammary growth, oestrogens and progesterone. For lactation to be maintained the mammary gland must also be stimulated by suckling (or milking) and ejection of milk. The effects of hormones on established lactation differ from species to species. Prolactin seems to play a central part in the hormonal control of lactation. Suckling, milking or other stimulation of the teat seems to be an adequate physiological stimulus for the release of prolactin and of oxytocin (which is essential for milk ejection). Two compounds, both of which are potent in human and animals, are helpful in investigations of the physiological role of prolactin in lactation in vivo: a specific inhibitor of the release of prolactin, the synthetic ergot alkaloid bromocriptine (2-bromo-α-ergocriptine, CB154), and a stimulator, the synthetic tripeptide of hypothalamic origin - thyroliberin (TRH). Experiments with these compounds indicate that large concentrations of prolactin in the circulation (especially after milking) are not needed for lactation to be maintained in ruminants but that prolactin is essential for the onset of lactation in these species. In contrast, prolactin is an essential hormone for lactogenesis and galactopoiesis in monogastric species like the rabbit, rat, pig, dog and human. The suckling stimulus is necessary for the maintenance of lactation in these species.
Article
An analysis of 235 patients with galactorrhea (5.5 per cent males) showed that 20 per cent of all patients, and 34 per cent of women with associated amenorrhea, had radiologically evident pituitary tumors; these patients had the highest serum prolactin concentrations. The largest single group (32 per cent) consisted of women with idiopathic galactorrhea without amenorrhea; prolactin was normal in 86 per cent of these cases. Five patients had the empty-sella syndrome. Prolactin response was tested in selected patients by thyrotropin-releasing hormone, chlorpromazine, L-dopa, 24-hour sampling and other means. Tests with thyrotropin-releasing hormone were most useful in identifying patients with pituitary tumors. Surgery and radiotherapy lowered prolactin to a similar degree in patients with tumor, but galactorrhea, and amenorrhea often persisted after treatment. The ergot derivatives, bromergocryptine and lergotrile mesylate, lowered prolactin in all 18 patients with idiopathic hyperprolactinemia or pituitary tumor, stopped galactorrhea in over 50 per cent, restored menses in over 70 per cent, and allowed pregnancy in three.
Article
The literature on conditions associated with abnormal lactation is reviewed. Abnormal pituitary prolactin secretion (hPRL) is not always related to lactation. This makes it difficult to classify galactorrhea-amenorrhea on the basis of pituitary dysfunction of hPRL secretion. Pharmacologic doses of estrogen can enhance hPRL secretion and promote breast enlargement when administered with intermittent thyrotrophin-releasing hormone (TRH). Withdrawal of medication results in milk production and letdown. hPRL is thought to have a free role in the uptake of estrogens by the mammary cells. A single injection of 150 mg of medroxyprogesterone acetate every 3 months increases lactation and duration of breast-feeding. The discontinuation of oral contraceptive use may result in galactorrhea-amenorrhea in some women. Nonsteroidal drugs such as reserpine tricyclic antidepressants methyldopa and opiates can cause abnormal lactation. Abnormal lactation may also accompany treatment for precocious puberty the McCune-Albright syndrome and the juvenile postabortion period. Chromophobe adenoma acromegaly Forbes-Albright syndrome occult pituitary neoplasia and pseudoneoplasia and hypothyroidism are associated with abnormal lactation. Some of the newer tests for the study of pituitary function in cases of abnormal lactation include the TRH stimulation test the phenothiazine stimulation test and the L-dopa test. The L-arginine infusion test and the insulin tolerance test are useful for the dissociation of growth hormone- and hPRL-secreting tumors. The successful removal of pituitary adenomas has been reported to restore cyclic gonadotropin secretion and cause galactorrhea to disappear. L-dopa and ergocryptine (CB-154) therapy have been successful in treating postpill amenorrhea-galactorrhea though L-dopa treatment has numerous undesirable side effects. It is suggested that prolactin secretion directly influences the secretion of cyclic gonadotropins and that the suppression of cyclic gonadotropin secretion and hyperprolactinemia are mainly indications of a disorder of catecholamine asecretion. Drugs that inhibit hPRL secretion should not be used to treat galactorrhea-amenorrhea without a thorough and exhaustive evaluation of prolactin secretion estrogen production and cyclic gonadotropin secretion.